- ICH GCP
- 미국 임상 시험 레지스트리
- Search trials
임상 시험 검색 : Gemcitabine, Oxaliplatin, Donafenib 및 Tislelizumab의 조합
총 9221 건
-
Assistance Publique - Hôpitaux de Paris종료됨
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University아직 모집하지 않음
-
Institut du Cancer de Montpellier - Val d'Aurelle완전한
-
Stichting Hemato-Oncologie voor Volwassenen NederlandDanish Lymphoma Group모병
-
The Lymphoma Academic Research OrganisationInnate Pharma모병
-
Second Affiliated Hospital, School of Medicine,...The First Affiliated Hospital of Zhengzhou University; The Affiliated Tumor Hospital of...모병
-
Second Affiliated Hospital, School of Medicine,...모병
-
The First Affiliated Hospital of Soochow University모병
-
Translational Research in OncologyBayer; Novartis빼는연조직 육종 | 소세포폐암 | 대장 신생물 | 항문 편평 세포 암종 | 악성 흉막 중피종 | 거세 저항성 전립선암 | 위장췌장 신경내분비종양 | 전립선의 신경내분비 암종
-
Sun Yat-sen University모병
-
Antengene Corporation모병말초 T 세포 림프종 | NK/T 세포 림프종중국
-
University Hospital, MontpellierFederation Francophone de Cancerologie Digestive모병절제 불가능한 담관암종 | 비전이성프랑스
-
Wuhan Union Hospital, China모병
-
Second Affiliated Hospital of Guangzhou Medical...완전한
-
Cancer Institute and Hospital, Chinese Academy...모병베바시주맙 | 카페시타빈 | 전이성 대장암(mCRC) | 옥살리플라틴 | 티슬레리주맙 | 첫 번째 줄 | MSS/pMMR | RAS 돌연변이중국
-
Samsung Medical Center완전한
-
National Health Research Institutes, TaiwanNational Taiwan University Hospital; Mackay Memorial Hospital; China Medical University Hospital 그리고 다른 협력자들완전한
-
Zhiyong Huang아직 모집하지 않음
-
Fujian Cancer Hospital아직 모집하지 않음
-
The First Affiliated Hospital of Zhengzhou University아직 모집하지 않음카페시타빈 | MSI-H 대장암 | 옥살리플라틴 | 티슬레리주맙
-
The University of Hong Kong알려지지 않은
-
Hebei Medical University Fourth Hospital모병
-
Dorte Nielsen완전한
-
Fujian Cancer Hospital모병
-
Indiana University School of MedicineAmgen완전한